Document is current
Any future updates will be listed below
-
Authors
Galluzzi, Lorenzo https://orcid.org/0000-0003-2257-8500
Galassi, Claudia
Wiest, David L https://orcid.org/0000-0002-0792-3188
- License Information
-
More Information
Article History
Received: 19 July 2025
Accepted: 31 July 2025
First Online: 26 August 2025
Disclosure and competing interests statement
: CG and DLW declare no competing interests. LG is/has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, AbbVie, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options.
